<DOC>
	<DOCNO>NCT00247559</DOCNO>
	<brief_summary>Despite wealth information literature regard cosmetic application botulinum type A toxin ( BoNT-A ) , widespread use BoNT-A cosmetic application , number randomise , control clinical trial small . Much publish information base open-label study anecdotal data . Of robust trial data available , vast majority relate treatment glabellar line , little data available regard use BoNT-A lateral canthal line . This study aim determine optimum dose use BoNT-A area .</brief_summary>
	<brief_title>Botulinum Type A Toxin Treatment Lateral Canthal Lines ( Crow 's Feet )</brief_title>
	<detailed_description />
	<criteria>Male female patient , 18 65 year age . In opinion Investigator moderate severe lateral canthal line ( crow ’ foot ) maximum smile side face . In opinion Investigator mild severe lateral canthal line ( crow ’ foot ) rest side face . Any prior surgery affect orbicularis oculi muscle , prior blepharoplasty brow lift , prior cosmetic procedure scar may interfere evaluation study result . Previous insertion nonabsorbable material periorbital region facial treatment augmentation material within 12 month prior screen . Any prior treatment botulinum toxin ( serotype ) . Previous treatment laser skin resurface treatment deep chemical peel within 12 month prior screen . Inability substantially lessen lateral canthal line physically spread apart . Facial condition could affect safety efficacy result : active infection skin problem periorbital area ( e.g . acute acne lesion ulcer ) ; history facial nerve palsy ; mark facial asymmetry ; ptosis ; excessive dermatochalasis ; deep dermal scarring ; thick sebaceous skin ; photodamage etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>crow 's foot</keyword>
	<keyword>cosmesis</keyword>
	<keyword>age</keyword>
</DOC>